+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interleukin-1 alpha, interleukin 6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro



Interleukin-1 alpha, interleukin 6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro



Apmis 104(3): 213-219



The proinflammatory cytokines interleukin 1 alpha (IL-1 alpha), tumor necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6) modulate the synthesis of complement factors B and C3 by endothelial cells (EC), and are considered to play an important role in the development of sepsis. By using agarose beads activating the alternative pathway of complement, we wanted to study the net effect of these cytokines on EC synthesis of the alternative and terminal pathways, measured by binding of anti-C3c and anti-TCC (terminal complement complex) antibodies to beads kept with the EC. Addition of IL-1 alpha and TNF alpha at concentrations of 50 and 100 U/ml resulted in a significant increase in binding of these antibodies to co-incubated beads, most pronounced for anti-C3c. IL-6 from 50-200 U/ml resulted in a stronger (two to fourfold) binding for both antibodies compared to experiments with IL-1 alpha and TNF. However, increased concentrations of IL-1 alpha (200 U/ml) and IL-6 (400 U/ml) resulted in a strong reduction in binding of anti-C3c and anti-TCC antibodies to the co-cultured beads. This study indicates that proinflammatory cytokines upregulate the synthesis by EC of the functional alternative and terminal pathways of complement.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046436553

Download citation: RISBibTeXText

PMID: 8611196


Related references

Activation of p42mapk in human umbilical vein endothelial cells by interleukin-1 alpha and tumor necrosis factor-alpha. American Journal of Physiology 274(3): C789-C798, 1998

Induction and release of manganese superoxide dismutase from mitochondria of human umbilical vein endothelial cells by tumor necrosis factor-alpha and interleukin-1 alpha. International Journal of Cancer 55(4): 646-650, 1993

Expression of vascular cell adhesion molecule-1 on human pulmonary artery endothelial cells and human umbilical vein endothelial cells stimulated by tumor necrosis factor-alpha, interleukin-1-beta and lipopolysaccharide. Yonago Acta Medica 40(1): 21-30, 1997

Effect of gamma-interferon on the synthesis of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro. Apmis 102(7): 554-558, 1994

Effects of baicalein isolated from Scutellaria baicalensis on interleukin 1-beta- and tumor necrosis factor alpha-induced adhesion molecular expression in cultured human umbilical vein endothelial cells. Journal of Ethnopharmacology 57(1): 63-67, 1997

Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha. Haematologica 84(4): 306-311, 1999

Interleukin-1-beta and tumor necrosis factor alpha signal through structurally distinct phosphatidic acid molecules in human umbilical vein endothelial cells. Clinical Research 42(2): 135A, 1994

The effect of interleukin-4 on tumour necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Thrombosis and Haemostasis 70(6): 1037-1042, 1993

Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. Journal of Pharmacology and Experimental Therapeutics 268(2): 1032-1039, 1994

Tumor necrosis factor-alpha regulates the proliferation and syndecan-4 expression of human umbilical vein endothelial-like cells cultured in vitro. Nan Fang Yi Ke Da Xue Xue Bao 27(4): 496-498, 2007

Tumor necrosis factor alpha tnf alpha interleukin 1 beta il 1 beta and interleukin 6 il 6 synthesis in human peripheral blood mononuclear cells pbmnc stimulated in vitro and in vivo by proteolytic enzymes. European Journal of Cancer 27(Suppl. 3): S75, 1991

Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. American Journal of Physiology 274(3): H883-H891, 1998

Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells: Effects of tumor necrosis factor alpha, interleukin 1 and phorbol ester. Biochemical Journal 296(3): 803-809, 1993

Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways. International Immunopharmacology 7(3): 343-350, 2007

Interleukin 4 antagonizes the interleukin 1 and tumor necrosis factor induced down regulation of thrombomodulin activity on human umbilical cord vein endothelial cells in culture. Blut 61(5): 326, 1990